Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD-sEMG Guided BoNT Injection for Chronic Pelvic Pain
NCT05062902Phase 1Not yet recruiting
- Sponsor
- HillMed
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by HillMed. Primary endpoint: Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMG. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05062902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062902.